Sort   by:  
 Page size 
GenomicsCharacterization of N-acetamide indoles as antimalarials
Characterization of N-acetamide indoles as antimalarials that target PfATP4
PRJEB81781 | ENA
ProteomicsDiscovering the N-terminal Methylome by the Repurposing of Proteomic Datasets
Protein ⍺-N-methylation is a cryptic and relatively unexplored post-translational modification involving the covalent addition of methyl groups to the free a-amino group at protein N-termini. To systematically explore the extent of ⍺-N-terminal methylation in yeast and humans, we utilized a repurpos...
ORGANISM(S): Saccharomyces cerevisiae (Baker's yeast) 
2021-05-26 | PXD022833 | Pride
Proteomics Post-translational modification Repurposing ⍺-n-terminal methylation 
UnknownOptical N-invariant of graphene's topological viscous Hall fluid.
Not available
S-EPMC8342470 | biostudies-literature
UnknownShot noise generated by graphene p-n junctions in the quantum Hall effect regime.
Not available
S-EPMC5426518 | biostudies-literature
UnknownRobust fractional quantum Hall effect in the N=2 Landau level in bilayer graphene.
Not available
S-EPMC5187585 | biostudies-literature
ProteomicsNovel N-terminal and lysine methyltransferases that target translation elongation factor 1A in yeast and human
Eukaryotic elongation factor 1A (eEF1A) is an essential, highly methylated protein that facilitates translational elongation by delivering aminoacyl-tRNAs to ribosomes. Here we report a new eukaryotic protein N-terminal methyltransferase, Saccharomyces cerevisiae YLR285W, which methylates eEF1A at a...
ORGANISM(S): Homo sapiens (Human) Saccharomyces cerevisiae (Baker's yeast) 
2015-11-10 | PXD002941 | Pride
Post-translational modifications N-terminus Lysine Methylation Methyltransferases 
UnknownDevelopment of gateless quantum Hall checkerboard <i>p-n</i> junction devices.
Not available
S-EPMC7558461 | biostudies-literature
GenomicsRNA-sequencing of ERBB3hi and ERBB3lo breast luminal progenitor cells from n=3 premenopausal BRCA2 mutation carriers and n=3 non-carriers [RNASeq_4_ERBB3]
RNA-sequencing of ERBB3hi and ERBB3lo breast luminal progenitor cells from n=3 premenopausal BRCA2 mutation carriers and n=3 non-carriers [RNASeq_4_ERBB3]
PRJNA975848 | ENA
GenomicsRNA-sequencing of ERBB3hi and ERBB3lo breast luminal progenitor cells from n=3 premenopausal BRCA2 mutation carriers and n=5 non-carriers [RNASeq_3_ERBB3]
RNA-sequencing of ERBB3hi and ERBB3lo breast luminal progenitor cells from n=3 premenopausal BRCA2 mutation carriers and n=5 non-carriers [RNASeq_3_ERBB3]
PRJNA975849 | ENA
Proteomics(Phospho)-proteomic characterization of longitudinal biopsies from HCC patients treated with sorafenib
Tumor response rates to targeted therapy are generally low. This poses an urgent medical need to identify molecular mechanisms that determine responsiveness, to inform drug development and therapy. Here, we performed a proteomics and phospho-proteomics (p)proteomics analysis on longitudinal tumor bi...
ORGANISM(S): Homo sapiens (Human) 
2026-04-27 | PXD028593 | Pride
Human Super-silac Sorafenib (phospho)-proteomics ((p)proteomics) Hepatocellular carcinoma (hcc) Biopsies 
Sort   by:  
 Page size